The Enable Lassa Fever Research programme, funded by the Coalition for Epidemic Preparedness Innovations (CEPI), was launched in 2019 to estimate the incidence of infection and disease due to Lassa Fever Virus in five West African countries (Benin, Guinea, Liberia, Nigeria and Sierra Leone). The study has successfully enrolled approximately 23,000 participants, who are now being followed up for a period of 24 months. As the coordinating partner, P95 ensures a high adherence to the planned implementation steps and epidemiological aspects of the program, working in close collaboration with other Programme Head Quarters partners (Epicentre, BNITM and MMARCRO), CEPI (funder) and the implementing partners in the countries. 

Read more about the project on the following websites:
https://cepi.net/news_cepi/largest-ever-lassa-fever-research-programme-launches-in-west-africa/?swcfpc=1 

https://epi.tghn.org/epidemiology/epi-studies/ 

Protocol paper coming soon.